chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized 12/6/2021-still admitted currently; COVID-19 positive 11/30/2021; fully vaccinated  History of Present Illness Patient is a 82 y.o. female  who presents to the hospital with shortness of breath.  The patient began having symptoms approximately 8 days ago.  She was seen in the walk-in clinic on 11/30 for symptoms of cough and congestion.  She was diagnosed with upper respiratory infection but also had a COVID test ordered which subsequently came back positive.  Throughout the course of the next several days she became increasingly fatigued with progressive cough and worsening shortness of breath.  Patient was seen in the emergency department.  She was afebrile but tachypneic in the 20s.  While there she required 6 L of oxygen to maintain sats above 90%.  Chest x-ray showed bilateral infiltrates consistent with possible COVID.  Due to her worsening hypoxemia she was transferred to the hospital for further evaluation care. Acute respiratory failure with hypoxemia  Assessment & Plan Likely related to COVID pneumonia in setting of mild chronic obstructive pulmonary disease Current required 4 L of oxygen Supportive care, wean as tolerated Instructed in incentive spirometry, flutter and proning   * Pneumonia due to COVID-19 virus Assessment & Plan Patient was symptom onset 8 days ago Vaccination status-vaccinated in April, no booster Patient with increasing cough shortness of breath and fatigue Positive test 11/30/2021 Admission 12/06/2021 Planned steroids, remdesivir and supportive care  Note from 12/13/2021: Acute respiratory failure with hypoxemia Assessment & Plan Likely related to COVID pneumonia in setting of mild chronic obstructive pulmonary disease More hypoxic this morning, CXR yesterday showing some disease progression IV lasix today Supportive care, wean as tolerated Instructed in incentive spirometry, flutter and proning  Currently on 60% HFNC   * Pneumonia due to COVID-19 virus Assessment & Plan Patient with symptom onset 11/29 Vaccination status-vaccinated in April, no booster Patient with increasing cough shortness of breath and fatigue Positive test 11/30/2021 Admission 12/06/2021 Dexamethasone 8/10 Remdesivir 5/5 Worsening hypoxia, CT negative for PE but does show basilar consolidative changes Check sputum culture, start empiric antibiotics Rocephin/azithro day 1/5
No initial symptoms after receiving the vaccine.  Next day woke up to extreme vertigo (Never had vertigo prior).  Lasted a couple hours before I could see straight.  Felt dizzy for the next 5 days.  Then around day 5 I started to see a arc shaped after image in my right eye.  waited about 4 days to see an optometrist since it persisted.  Nothing significant on the first ophthalmoscopy.  A few days later noticed blurring around the area where the after imaging was.  Saw the optometrist again about 1 week after original visit (now September 13th), did an OCT and found a cotton wool spot had formed.  Referred to Ophthalmology. about 2 days later confirmed cotton wool spot, determined no need for treatment, just monitor to let it heal its course.  Almost 1 year later the scotoma in my right eye still persists.  2nd Development.  December 13th, my left eyes left-most peripheral vision started going black for about 1-2 seconds then returning.  This would happen about 25-40 times a day spread out.  I saw my ophthalmologist next day.  no findings via exam or imaging, recommend to neurology.  I went to the ER that night, over the next two days I have a CTA of head and neck, and MRA of head, orbital, cervical and thoracic spine, with no findings.  EKG and Echo Cardiogram was also done.  Went home on the 16th.  Followed up with ER recommendations to Neuro-opthamology at both Clinic and eye facility.  No findings from both exams.  Both doctors determined by ruling out other possibilities that it is a very atypical retinal/ocular migraine.  These symptoms persisted daily until February of 22nd, where occasionally I would get a few days of a break.  By March it started becoming less frequent.  And current it seems to only reoccur every once in a while.
Severe headache, severe body aches, shortness of breath,  fever, chills, severe fatigue and nausea
noted fever last noc of t101.4 about early evening p/receiving shots; 8AM next morning swelling to lt leg approx 5.7cm in diameter appearing like a red raised papular rash; MD stated allergic reaction;
About 2 days after the injection I had a very sharp pain in my left shoulder that lasted for barely a second. I  continued to have similar pains from time to time, but this increased to several times a day, lasting longer and over a larger area,  and in the past couple of weeks it has become quite painful with certain motions of my arm. When I sought information yesterday, I  found info about SIRVA, and called my primary care doctor, listed above in this form. He said to report to you.
shrill abn inconsolable crying w/in a couple hrs of immun cont for over 24 hrs; t101.9 @ ER 19MAY93, 5PM treated w/APAP & children's Advil;
Started with a rash on my face 5 days post vaccine that continued to spread to arms, stomach, back & thighs  blistered in some areas
PT is a very pleasant 57yo F who presented to the ED last evening for evaluation of ongoing dyspnea and cough. She received both Pfizer vaccinations in March/April 2021. She developed symptoms of sore throat, cough, and dyspnea on 9/20/21 and tested positive on 9/21/21. She was eligible for mAb therapy and received Regeneron on 9/23/21 through her PCP's office. Since then, she has had progressive worsening of her dyspnea and cough despite prednisone and nebulized breathing treatments she started on 9/24/21. She also had diarrhea several days ago but reports it had improved somewhat yesterday prior to presentation in the ED. No chest pain. No fever or chills. No nausea or vomiting. Reports abdominal "tenderness that has been present for at least several weeks that she attributes to a previous MVC.   Her medical history is significant for COPD (diagnosed earlier this year), hypertension, hypothyroidism, hyperlipidemia, history of MVC in 2018 with multiple traumatic fractures. She quit smoking in August of this year after her COPD diagnosis.   In the ED, she was hypoxic to 88% on room air and has been requiring 1-2L O2 overnight.  P10/6/2021 PT is a pleasant 57 year old female recently discharged from our facility after a hospitalization for severe COVID-19 disease.  She was discharged on a continuing prednisone taper and nocturnal home O2.  She unfortunately fell one day after returning home and sustained compression fractures of her L2, L3 and L5 vertebrae.  She has experienced poorly controlled pain and debility secondary to the above.  Fortunately her COVID symptoms including severe cough and dyspnea have mostly resolved.  I am happy to admit her for PT / OT evaluation and pain control.
Patient experienced nausea, vomiting, diarrhea, headache and fever (101 F) from 10:00 pm 03/18/21 to 12:00 pm 03/19/21.
Moderate soreness at injection site; tiredness; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 at 12:00 as dose 4 (booster), single (Lot number: GJ6742) at the age of 35 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies Sulfa drugs" (unspecified if ongoing). Concomitant medication(s) included: NEXPLANON. Past drug history included: Morphine, reaction(s): "Known allergies morphine", notes: Known allergies morphine. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 21Oct2022 at 16:00, outcome "recovering", described as "Moderate soreness at injection site"; HEADACHE (non-serious) with onset 21Oct2022 at 16:00, outcome "recovering"; FATIGUE (non-serious) with onset 21Oct2022 at 16:00, outcome "recovering", described as "tiredness". Therapeutic measures were not taken as a result of vaccination site pain, fatigue, headache.  Additional information: Facility type vaccine was workplace clinic. Patient did not receive any other vaccine in four weeks. Patient did not have covid prior vaccination and not tested covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Local tenderness, cough, sore throat, swelling of uvula, malaise, myalgia, fever up to 101.
made my jaw shrink; my muscles atrophy; I suffer from more atrophy; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), administration date 22Dec2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "my teeth were shaved" (unspecified if ongoing); "atrophy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: JAW DISORDER (non-serious) with onset Dec2021, outcome "unknown", described as "made my jaw shrink"; MUSCLE ATROPHY (non-serious) with onset Dec2021, outcome "unknown", described as "my muscles atrophy"; ATROPHY (non-serious) with onset Dec2021, outcome "unknown", described as "I suffer from more atrophy".  Additional information: Additional information: patient have a smaller chin because of it.Patient a professional fighter. The Pfizer vaccination may have ruined my career and my life or at least contributed to it. Patient was not going to get it but because its so hard to move around with the covid virus, patient got it so can travel freely". The patient reports " chin were literally, when patient rub face and chin was so high up, patient don't have a chin anymore, patient so boney, all my muscles atrophied, what patient supposed to do How supposed to get compensated. patient supposed to get a second vaccination and then what, then my chin really disappear and patient have no chin should be compensated." The patient reports that just saw several oral maxiofacial surgeons in several countries because 15 months ago patient was the victim of malpractice, teeth were shaved, it was improper practice, pateint didn't need to have them shaved. Once the enamel is secreted the bone re absorbs, after that atrophy kicked in, over time more atrophy kicked in, now patient lost all of muscles and look like an old person. patient got the coronavirus vaccination and suffer from more atrophy. "This vaccination screwed me up even more. "The patient declined to file a safety report. Declined to provide name or contact information. The patient went on to say "I noticed this before the vaccine. All the people that advertise for the vaccination, have disgusting smiles, their lips are ripped open, they have poor bone, they aren't the type of people getting punched in the face, they aren't strong people. Then I get the vaccination and my jaw shrinks more, after patient victim of malpractice.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt began c/o blurred vision and sweaty palms. Pt states she did not eat breakfast. Fingerstick 110, pt given apple juice and one hard candy. Pt was able to distinguish how many fingers was holding up. BP 125/80, HR 92. Pt AOx3. Pt has bilateral upper & lowe extremity strength 5/5. After 30 min of unresolved blurred vision, patient escorted to ER.
Myalgia, Diarrhea, NauseaVomiting, chills and left arm pain developed n,v d Narrative:
administrated only the diluent portion of the vaccine; administrated only the diluent portion of the vaccine; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 77-year-old female patient who received Herpes zoster (Shingrix) (batch number 99e53, expiry date 9th April 2023) for prophylaxis.   On 26th October 2021, the patient received Shingrix. On 26th October 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The patient was inadvertently administrated only the diluent portion of the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  No further events were reported. The reporter consented to follow up. The vaccine administration facility was the same as primary reporter. This case has been linked to the case US2022016942 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022016942:same reporter
Fever,dry mouth, stomach ache.  Fainted, turned green in complexion.  Arm swell, heat and redness at injection sight.
Pt. states that after receiving the 3rd Booster of Moderna 11/01/2021, started experiencing symptoms 11/02/2021 of muscle (shoulder) aches and burning sensation on top area of thighs. Symptoms are still continuing with the burning sensation in the thighs turning to numbness and pain throughout both arms. Primary visit 11/10/2021 recommendation of Follow-Up Anti-Inflammatory medication.
1 day after vaccination, pt developed erythema, edema over L arm at site of injection, with prominent, fluctuant olecranon bursa.  Treated with ibuprofen, ice, elevation also with dicloxacillin with differential dx. of cellulitis.
Headache; Tired; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 12Jun2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Jun2021, the patient experienced headache, tired and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, tired and sore arm were recovered on an unknown date in Jun2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT CALLED AND STATED THAT HE HAD A HEART ATTACK ON 3/14/21.  (TEN DAYS AFTER THE VACCINATION)  HE STATES THAT HE CALLED THE DEPARTMENT OF HEALTH AND WAS TOLD TO CONTACT THE LOCATION WHERE HE RECEIVED THE VACCINATION.
Red, itchy bumps on palms like hand foot and mouth, but no fever.  Then some around toes and on feet.  Woke up next morning with pox on both thighs, but no itching there.  Rash has spread to backs of hands, further up feet.  Thighs still don't itch.  Bumps on hands and feet are painful now.
Extreme chills, headaches, aches and pains, lethargic and bloody nose
Scaly hands/Rough hands/ Dry hands; rash on inside of fingers of both hands, rash on both palm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (Scaly hands/Rough hands/ Dry hands) and RASH (rash on inside of fingers of both hands, rash on both palm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced RASH (rash on inside of fingers of both hands, rash on both palm). On 10-Mar-2021, the patient experienced SKIN EXFOLIATION (Scaly hands/Rough hands/ Dry hands). The patient was treated with WHITE SOFT PARAFFIN (AQUAPHOR [WHITE SOFT PARAFFIN]) at a dose of 1 dosage form; PARAFFIN (MOISTURIZER) ongoing since an unknown date at a dose of 1 dosage form and CORTISONE ACETATE (CORTISONE [CORTISONE ACETATE]) at a dose of 1 dosage form. On 10-Mar-2021, RASH (rash on inside of fingers of both hands, rash on both palm) had resolved. At the time of the report, SKIN EXFOLIATION (Scaly hands/Rough hands/ Dry hands) outcome was unknown.            No concomitant medications provided.  The patient received both scheduled doses of mRNA-1273 , therefore action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up was received and  reporter's contact information was updated.
Child was brought in to clinic on 11/23/2009 - with what is believed to be reaction to the H1N1 vaccine that was given on 11/21/2009. Vaccine given at 0930 and by 7pm broke out in hives. Child was on amoxicillin x8days starting on 11/14/09 prior to vaccine.
Arm/shoulder pain, decreased range of motion of arm, unable to perform lifting at work, multiple absences from work.
At 9:30 am per vaccinator , patient lost consciousness for less than 2 seconds with no injury.  Patient was assessed and was coherent. VS obtained. BP 90/60. Pulse 63. Respirations 14. O2 sat 99%. Denied shortness of breath, throat swelling, nausea or headache. Was able to change position from lying to sitting. Patient was transferred to second floor clinic via wheelchair for further evaluation. 10:40am Care handed over to nurse.
10 X 10cm area of erythema and induration at site of DTaP vaccine. Area or erythema and induration increased to involve erythema upper arm.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 11-JUL-2017 and 12-JUL-2017, unspecified number of patients were vaccinated with improperly stored doses of PROQUAD lot# M042499 with expiry date: 17-APR-2018 (dosing details, route were unknown) for prophylaxis. It was reported that the vaccines were exposed to a temperature range of 6 F to 14 F for a duration of 1 hour. Data Logger was involved. There were no previous temperature excursions. No adverse effects were reported. This is one of the two reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA005971: Original Case: 1707USA005971.
Swollen painful warm right arm with redness noted of arm marked area measuring approximately 10 inches in diameter.
Patient went unconscious for almost 3 hours; Critical until he wasn't critical; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Patient went unconscious for almost 3 hours) and CRITICAL ILLNESS (Critical until he wasn't critical) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patients had neurological workup and cannot drive for 6 months.     On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (Patient went unconscious for almost 3 hours) (seriousness criterion medically significant) and CRITICAL ILLNESS (Critical until he wasn't critical) (seriousness criterion medically significant). At the time of the report, LOSS OF CONSCIOUSNESS (Patient went unconscious for almost 3 hours) and CRITICAL ILLNESS (Critical until he wasn't critical) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Apr-2021, Blood test: blood work clear (normal) Blood work clear. On 24-Apr-2021, Chest X-ray: chest x-ray clear (normal) Chest X-ray clear. On 24-Apr-2021, Computerised tomogram: cat scan clear (normal) CAT scan clear.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient went unconscious for almost 3 hours. the patient almost lift flighted to the hospital but could not and ended up calling an ambulance and brought him to the hospital where they kept him from 7:15 AM to 3:30 PM. After the patient woke up he was completely fine. The reporter disclosed that during the wait for the flight, they had to do continuous sternum rub on him.  Treatment for the events included IV fluids and NS saline.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Two consecutive late periods and changes in cervical fluid and position compared to previous periods which were once predictable give or take a day.
Swelling at injection site, arm pain, pain in wrists/shoulders/knees.  Felt ill, very poor energy, poor appetite.
Janssen vaccine was administered as 2nd dose instead of Pfizer vaccine.  Client had received 1st Pfizer vaccine 2/18/22 and was given Janssen 3/18/22.
Woke up 20 hours after the vaccine with a fever of 100.4* , chills and fatigue. Lasted for about 12 hours , slept with Advil and woke up the next day (48 hours after the vaccine) and felt 100% better. This was my first shot and I had Covid in February that lasted 14 days. I am in excellent health, non-smoker and no under lying conditions. Very athletic and height to weight ratio is excellent.  I am due to get my second shot/booster on June 14th and I am nervous that I may have the same reaction.
Mild Headache; Flushing; Nausea Monitored for 35 mintes  Symptoms resolved prior to being released to home.
I have been on Humira for more than 14 years with a year off in approximately 2018.  I have had either the TST or Quantiferon test every year per my physicians' orders.  All tests have been negative.  My last negative test was in February 2020 and was the Quantiferon test.  I had the Quantiferon test performed on 3/18/21 which came back positive.  I was retested on 4/6/21 and it was again positive.  The first test was administered 3 weeks after the second Pfizer vaccine.  CDC guidelines recommend waiting at least 4 weeks after the vaccine was administered so I had the second test.
Patient presented on 11/12/09 with left upper back and shoulder pain in trapezius area.  Patient also complains of left deltoid weakness and atrophy.  Patient had needle EMG of left upper extremity on 12/15/09 with the following findings: abnormal consistent with acute/subacute denervation with some motor unit loss and evidence of reinnervation in a upper brachial plexus/C5-5 nerve root distribution with sparing of the rhomboids (pure C5 nerve root innervation).  Needle EMG of the cervical paraspinal muscles at the C5-6 spinous process level was normal, but C7-T1 level muscles showed abnormal consistent with acute/subacute denervation.  Cervical paraspinal muscles may have significant segmental overlap, therefore these findings are most consistent C6 radiculopathy.  Patient had been treated with ibuprofen without response, Percocet without response, and some response to prednisone (decrease in pain to 2 out of 10, but weakness persisted).  Patient is now seeing physical therapy for modalities and strengthening.